<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"mitsubishitanabe" - Google News</title><link>https://news.google.com/search?cf=all&amp;hl=en-US&amp;q=mitsubishitanabe&amp;cf=all&amp;gl=US&amp;ceid=US:en</link><language>en-US</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 14 Jun 2026 06:38:42 GMT</lastBuildDate><image><title>Google News</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google News</description><item><title>Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America - PR Newswire</title><link>https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUVVJY1piSDhnS282S1h5eEV3QVdueWFDbkU1MEMtRHFSay1jZDdNNkNoZFJZUTNiZWk5eWwzaWlDaDJrczNTVzlqV3NZSnZJZ0QyaXJ0aHpxSWpUVEFXLWRteWRKV2cyODV3ckc1N0lwSXFLeklvcDVSNG9KY2lVM01EcHkxT2xvNmcwRkE5R0dYUzBkc0pucWlBSjJOcnBGZmlWcWgxTXVMSUJxT3QwWWg0N2dWazVT?oc=5</link><guid isPermaLink="false">CBMiuAFBVV95cUxNUVVJY1piSDhnS282S1h5eEV3QVdueWFDbkU1MEMtRHFSay1jZDdNNkNoZFJZUTNiZWk5eWwzaWlDaDJrczNTVzlqV3NZSnZJZ0QyaXJ0aHpxSWpUVEFXLWRteWRKV2cyODV3ckc1N0lwSXFLeklvcDVSNG9KY2lVM01EcHkxT2xvNmcwRkE5R0dYUzBkc0pucWlBSjJOcnBGZmlWcWgxTXVMSUJxT3QwWWg0N2dWazVT</guid><pubDate>Mon, 01 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUVVJY1piSDhnS282S1h5eEV3QVdueWFDbkU1MEMtRHFSay1jZDdNNkNoZFJZUTNiZWk5eWwzaWlDaDJrczNTVzlqV3NZSnZJZ0QyaXJ0aHpxSWpUVEFXLWRteWRKV2cyODV3ckc1N0lwSXFLeklvcDVSNG9KY2lVM01EcHkxT2xvNmcwRkE5R0dYUzBkc0pucWlBSjJOcnBGZmlWcWgxTXVMSUJxT3QwWWg0N2dWazVT?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Shionogi shells out $2.5B for Mitsubishi Tanabe's ALS drug - FirstWord Pharma</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTE15YmlHWXBqdURZTlFCWl9uREJkZksxOXBSNmtlZnVmcXhYZU5vOFJBZ25IQjVuUnllS0NqcEJxWFE0dk1YVTV6UlZXMW5mWldqdHRB?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTE15YmlHWXBqdURZTlFCWl9uREJkZksxOXBSNmtlZnVmcXhYZU5vOFJBZ25IQjVuUnllS0NqcEJxWFE0dk1YVTV6UlZXMW5mWldqdHRB</guid><pubDate>Mon, 22 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE15YmlHWXBqdURZTlFCWl9uREJkZksxOXBSNmtlZnVmcXhYZU5vOFJBZ25IQjVuUnllS0NqcEJxWFE0dk1YVTV6UlZXMW5mWldqdHRB?oc=5" target="_blank"&gt;Shionogi shells out $2.5B for Mitsubishi Tanabe's ALS drug&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;FirstWord Pharma&lt;/font&gt;</description><source url="https://firstwordpharma.com">FirstWord Pharma</source></item><item><title>FDA slaps CRL on Mitsubishi Tanabe’s investigational ND0612 - The Pharma Letter</title><link>https://news.google.com/rss/articles/CBMipgFBVV95cUxOcnluemN5VDhPdVdDYXk5bDhMZXd2U2dTekVKemtLZXVJRXhEMVRVZEtxWUZTQUFfRG4tZldHSDFicExMRjVvbG0xOXVMekllajlQQkFKWFE4S0w3aXJpR1lORExyM2hnV1kxY1VYRHNycTllZ1RicklxY2w3d2NZT09jUzJuM2VLUl92bUJWNk9MU04tcDhBOW1KX1I4WENHZjBrV1F3?oc=5</link><guid isPermaLink="false">CBMipgFBVV95cUxOcnluemN5VDhPdVdDYXk5bDhMZXd2U2dTekVKemtLZXVJRXhEMVRVZEtxWUZTQUFfRG4tZldHSDFicExMRjVvbG0xOXVMekllajlQQkFKWFE4S0w3aXJpR1lORExyM2hnV1kxY1VYRHNycTllZ1RicklxY2w3d2NZT09jUzJuM2VLUl92bUJWNk9MU04tcDhBOW1KX1I4WENHZjBrV1F3</guid><pubDate>Fri, 24 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOcnluemN5VDhPdVdDYXk5bDhMZXd2U2dTekVKemtLZXVJRXhEMVRVZEtxWUZTQUFfRG4tZldHSDFicExMRjVvbG0xOXVMekllajlQQkFKWFE4S0w3aXJpR1lORExyM2hnV1kxY1VYRHNycTllZ1RicklxY2w3d2NZT09jUzJuM2VLUl92bUJWNk9MU04tcDhBOW1KX1I4WENHZjBrV1F3?oc=5" target="_blank"&gt;FDA slaps CRL on Mitsubishi Tanabe’s investigational ND0612&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Pharma Letter&lt;/font&gt;</description><source url="https://www.thepharmaletter.com">The Pharma Letter</source></item><item><title>Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Bain Capital</title><link>https://news.google.com/rss/articles/CBMilAFBVV95cUxOVEtXb3VZNmVWdW1OZzNrZUQ0TkRCd3U4N3ZiZUxkRGJOWllMMnQtZmdvMjB3eVNndHRhaEZBLTg0NklYODdoMGpXeG1IQmJIajcxck9peG56enV6a3ExZDM5cmVOUWRsSjNoWEdkRnlKSEpJTkxrTzlrVzhpUFNYR2pySU9QYkphSXRXX0hqSFVOYkNH?oc=5</link><guid isPermaLink="false">CBMilAFBVV95cUxOVEtXb3VZNmVWdW1OZzNrZUQ0TkRCd3U4N3ZiZUxkRGJOWllMMnQtZmdvMjB3eVNndHRhaEZBLTg0NklYODdoMGpXeG1IQmJIajcxck9peG56enV6a3ExZDM5cmVOUWRsSjNoWEdkRnlKSEpJTkxrTzlrVzhpUFNYR2pySU9QYkphSXRXX0hqSFVOYkNH</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOVEtXb3VZNmVWdW1OZzNrZUQ0TkRCd3U4N3ZiZUxkRGJOWllMMnQtZmdvMjB3eVNndHRhaEZBLTg0NklYODdoMGpXeG1IQmJIajcxck9peG56enV6a3ExZDM5cmVOUWRsSjNoWEdkRnlKSEpJTkxrTzlrVzhpUFNYR2pySU9QYkphSXRXX0hqSFVOYkNH?oc=5" target="_blank"&gt;Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Bain Capital&lt;/font&gt;</description><source url="https://www.baincapital.com">Bain Capital</source></item><item><title>Mitsubishi Tanabe Names New CEO In C-Suite Reshuffle - Citeline News &amp; Insights</title><link>https://news.google.com/rss/articles/CBMi0gFBVV95cUxOT0J5bjNHSWJHdVluOTlpTEQ4S0kzaXdHOGZLYklaenpQVlh0WjM4WngwTlJQWFdpcFRmYTJ6Um40d0xSVzI1MW54SDlfeU9CTXotVFFjcnBsYkE4V1RGYTFLaTVEdF9hVDQ2N0Zzc0tmLWFxaTVDdExVanlRd3BOTVNkTVpiY1FkZnYxLW5STER2MlVJM2RRclNOWnhXNzRoSExlVmhOcThpUEh3a2tVTTROSFlpUlNHaW5vcXk4RVo2WkRUdDhKOUJLcS1iTk13WHc?oc=5</link><guid isPermaLink="false">CBMi0gFBVV95cUxOT0J5bjNHSWJHdVluOTlpTEQ4S0kzaXdHOGZLYklaenpQVlh0WjM4WngwTlJQWFdpcFRmYTJ6Um40d0xSVzI1MW54SDlfeU9CTXotVFFjcnBsYkE4V1RGYTFLaTVEdF9hVDQ2N0Zzc0tmLWFxaTVDdExVanlRd3BOTVNkTVpiY1FkZnYxLW5STER2MlVJM2RRclNOWnhXNzRoSExlVmhOcThpUEh3a2tVTTROSFlpUlNHaW5vcXk4RVo2WkRUdDhKOUJLcS1iTk13WHc</guid><pubDate>Mon, 01 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxOT0J5bjNHSWJHdVluOTlpTEQ4S0kzaXdHOGZLYklaenpQVlh0WjM4WngwTlJQWFdpcFRmYTJ6Um40d0xSVzI1MW54SDlfeU9CTXotVFFjcnBsYkE4V1RGYTFLaTVEdF9hVDQ2N0Zzc0tmLWFxaTVDdExVanlRd3BOTVNkTVpiY1FkZnYxLW5STER2MlVJM2RRclNOWnhXNzRoSExlVmhOcThpUEh3a2tVTTROSFlpUlNHaW5vcXk4RVo2WkRUdDhKOUJLcS1iTk13WHc?oc=5" target="_blank"&gt;Mitsubishi Tanabe Names New CEO In C-Suite Reshuffle&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Citeline News &amp; Insights&lt;/font&gt;</description><source url="https://insights.citeline.com">Citeline News &amp; Insights</source></item><item><title>Sanofi Korea transfers MS drug Aubagio rights to Mitsubishi Tanabe - koreabiomed.com</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9jZ1VoZG1FYmQ1Wi1HMUNWaDRTbHNMbHREam1xRnRVRzR0UnBlZmtJNEs2UkRfMXZJdzl3d3lrc05mV1UtUURkWlV6Y2NIZkhXUmN5MmNQV0hoU3dXMzIxQ1JnTEJES1l3aTN2dDJR0gFyQVVfeXFMTkNxZU1iQlQ5LXpDUUdiVVZtVEM5M2k4V2tKSFNpZ3p2QkhRdDhGeEFtWnhVb1lrNWVleGg1WW0zNlhaLTduelNWZ2luNjdoZWhydEwyQl9FcDRfa0k5bDlON3gtdHFXUGJhbWNTMzNZd21n?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9jZ1VoZG1FYmQ1Wi1HMUNWaDRTbHNMbHREam1xRnRVRzR0UnBlZmtJNEs2UkRfMXZJdzl3d3lrc05mV1UtUURkWlV6Y2NIZkhXUmN5MmNQV0hoU3dXMzIxQ1JnTEJES1l3aTN2dDJR0gFyQVVfeXFMTkNxZU1iQlQ5LXpDUUdiVVZtVEM5M2k4V2tKSFNpZ3p2QkhRdDhGeEFtWnhVb1lrNWVleGg1WW0zNlhaLTduelNWZ2luNjdoZWhydEwyQl9FcDRfa0k5bDlON3gtdHFXUGJhbWNTMzNZd21n</guid><pubDate>Mon, 15 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9jZ1VoZG1FYmQ1Wi1HMUNWaDRTbHNMbHREam1xRnRVRzR0UnBlZmtJNEs2UkRfMXZJdzl3d3lrc05mV1UtUURkWlV6Y2NIZkhXUmN5MmNQV0hoU3dXMzIxQ1JnTEJES1l3aTN2dDJR0gFyQVVfeXFMTkNxZU1iQlQ5LXpDUUdiVVZtVEM5M2k4V2tKSFNpZ3p2QkhRdDhGeEFtWnhVb1lrNWVleGg1WW0zNlhaLTduelNWZ2luNjdoZWhydEwyQl9FcDRfa0k5bDlON3gtdHFXUGJhbWNTMzNZd21n?oc=5" target="_blank"&gt;Sanofi Korea transfers MS drug Aubagio rights to Mitsubishi Tanabe&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;koreabiomed.com&lt;/font&gt;</description><source url="https://www.koreabiomed.com">koreabiomed.com</source></item><item><title>Mitsubishi Tanabe Pharma Canada is Now Tanabe Pharma Canada - PR Newswire Canada</title><link>https://news.google.com/rss/articles/CBMisgFBVV95cUxOMVZzNkN1bHJIWVZ5RWw5bjloR0dzSHpabUxlekRMN3QwZjEzSEltanY5ZWJUS0RkUDlSN2o4Q1JYNkEzTDZ5aGpXLXBPa3BJd0pIWGw4enlLUHZOemROVGxkeDJzdFpvWnpHSVEwbTRqSFU1UThJOUQ5TDNXWjdMZXYwTV9zTS1NZ2VpSU83LVBWT1lfaHVUSUUyUl8yX1kyd1VKdjFIalhuWndob3FxdGd3?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxOMVZzNkN1bHJIWVZ5RWw5bjloR0dzSHpabUxlekRMN3QwZjEzSEltanY5ZWJUS0RkUDlSN2o4Q1JYNkEzTDZ5aGpXLXBPa3BJd0pIWGw4enlLUHZOemROVGxkeDJzdFpvWnpHSVEwbTRqSFU1UThJOUQ5TDNXWjdMZXYwTV9zTS1NZ2VpSU83LVBWT1lfaHVUSUUyUl8yX1kyd1VKdjFIalhuWndob3FxdGd3</guid><pubDate>Mon, 01 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOMVZzNkN1bHJIWVZ5RWw5bjloR0dzSHpabUxlekRMN3QwZjEzSEltanY5ZWJUS0RkUDlSN2o4Q1JYNkEzTDZ5aGpXLXBPa3BJd0pIWGw4enlLUHZOemROVGxkeDJzdFpvWnpHSVEwbTRqSFU1UThJOUQ5TDNXWjdMZXYwTV9zTS1NZ2VpSU83LVBWT1lfaHVUSUUyUl8yX1kyd1VKdjFIalhuWndob3FxdGd3?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma Canada is Now Tanabe Pharma Canada&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire Canada&lt;/font&gt;</description><source url="https://www.newswire.ca">PR Newswire Canada</source></item><item><title>Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn - Pharmaceutical Technology</title><link>https://news.google.com/rss/articles/CBMiogFBVV95cUxONllSNlJHYjI3M1BXbW5tMjdRaEhNREYtRWRhTFpMOU1vNVFIT19sY1JWc1dFdmZPQzk2WDV4X00zOU00MWo3M0x4Zm9GNXM5SEdOcWlGUW9PRDFXVUgzbHhGVG9ERjlwUGtRbi1uUFlCcW8tY1BNb3ptOGdaOGhKamMxNFJzalFOV2szWFR2R0dIRjN0anhJX1MzNUVsTWIxN1E?oc=5</link><guid isPermaLink="false">CBMiogFBVV95cUxONllSNlJHYjI3M1BXbW5tMjdRaEhNREYtRWRhTFpMOU1vNVFIT19sY1JWc1dFdmZPQzk2WDV4X00zOU00MWo3M0x4Zm9GNXM5SEdOcWlGUW9PRDFXVUgzbHhGVG9ERjlwUGtRbi1uUFlCcW8tY1BNb3ptOGdaOGhKamMxNFJzalFOV2szWFR2R0dIRjN0anhJX1MzNUVsTWIxN1E</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxONllSNlJHYjI3M1BXbW5tMjdRaEhNREYtRWRhTFpMOU1vNVFIT19sY1JWc1dFdmZPQzk2WDV4X00zOU00MWo3M0x4Zm9GNXM5SEdOcWlGUW9PRDFXVUgzbHhGVG9ERjlwUGtRbi1uUFlCcW8tY1BNb3ptOGdaOGhKamMxNFJzalFOV2szWFR2R0dIRjN0anhJX1MzNUVsTWIxN1E?oc=5" target="_blank"&gt;Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmaceutical Technology&lt;/font&gt;</description><source url="https://www.pharmaceutical-technology.com">Pharmaceutical Technology</source></item><item><title>Costa Saroukos Appointed as Chairman of the Board at Mitsubishi Tanabe Pharma - hrtoday.in</title><link>https://news.google.com/rss/articles/CBMingFBVV95cUxNQmxrbjc2aUVwMmwzT09wUW9OZEIxU0VuMk5sMDMwX3pLd3RrZmdJMmJlcVdQZ1NFanlxdEl4VWZOTzRORXUxc1M1N3VLZXRvTkdxZ3hLN1I0OXVaSkVnZU02QzRCb1VlbjE1NmZoUWt6NDA1aUdieGJBc05wZUNTUGx5QVhHZC1xMWNjSmY2VmMtbk5mTzQ2eTlIWjBrZw?oc=5</link><guid isPermaLink="false">CBMingFBVV95cUxNQmxrbjc2aUVwMmwzT09wUW9OZEIxU0VuMk5sMDMwX3pLd3RrZmdJMmJlcVdQZ1NFanlxdEl4VWZOTzRORXUxc1M1N3VLZXRvTkdxZ3hLN1I0OXVaSkVnZU02QzRCb1VlbjE1NmZoUWt6NDA1aUdieGJBc05wZUNTUGx5QVhHZC1xMWNjSmY2VmMtbk5mTzQ2eTlIWjBrZw</guid><pubDate>Tue, 02 Sep 2025 11:42:04 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNQmxrbjc2aUVwMmwzT09wUW9OZEIxU0VuMk5sMDMwX3pLd3RrZmdJMmJlcVdQZ1NFanlxdEl4VWZOTzRORXUxc1M1N3VLZXRvTkdxZ3hLN1I0OXVaSkVnZU02QzRCb1VlbjE1NmZoUWt6NDA1aUdieGJBc05wZUNTUGx5QVhHZC1xMWNjSmY2VmMtbk5mTzQ2eTlIWjBrZw?oc=5" target="_blank"&gt;Costa Saroukos Appointed as Chairman of the Board at Mitsubishi Tanabe Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;hrtoday.in&lt;/font&gt;</description><source url="https://hrtoday.in">hrtoday.in</source></item><item><title>Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMivgFBVV95cUxNakJMS0syRGI3Njh0RGVXRlhlR2tlQndMd2d3eXdISVNZdDJ6emplZm45dE9yQ2pDQkh6UjFxcFhVYUUtdWNOQmxVYWs4d1p4eURyTlZjOWFHMXhfTVhGU3NudGYyTzJPT2t0R3l5YWV5S29oaVN6WHJIdzlWaURsUlZWWUNJc0QtTmZCS3JlQnRxX0pWT3piay1ZZ044VFZWRmRsZUdGbnhrd1Y1SUJPdVN1S29uYnJBb0RyUDBn?oc=5</link><guid isPermaLink="false">CBMivgFBVV95cUxNakJMS0syRGI3Njh0RGVXRlhlR2tlQndMd2d3eXdISVNZdDJ6emplZm45dE9yQ2pDQkh6UjFxcFhVYUUtdWNOQmxVYWs4d1p4eURyTlZjOWFHMXhfTVhGU3NudGYyTzJPT2t0R3l5YWV5S29oaVN6WHJIdzlWaURsUlZWWUNJc0QtTmZCS3JlQnRxX0pWT3piay1ZZ044VFZWRmRsZUdGbnhrd1Y1SUJPdVN1S29uYnJBb0RyUDBn</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNakJMS0syRGI3Njh0RGVXRlhlR2tlQndMd2d3eXdISVNZdDJ6emplZm45dE9yQ2pDQkh6UjFxcFhVYUUtdWNOQmxVYWs4d1p4eURyTlZjOWFHMXhfTVhGU3NudGYyTzJPT2t0R3l5YWV5S29oaVN6WHJIdzlWaURsUlZWWUNJc0QtTmZCS3JlQnRxX0pWT3piay1ZZ044VFZWRmRsZUdGbnhrd1Y1SUJPdVN1S29uYnJBb0RyUDBn?oc=5" target="_blank"&gt;Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma - WSJ</title><link>https://news.google.com/rss/articles/CBMingFBVV95cUxPX3RRWDZjZWQwUHNVdDBlRjlOZnl1MkNQV09WUTlGVXZ3VVN5U2ZRNk9IRFhIYmJfcnZCTW5JUnRkMnc3RWlXbHQzUVo2M3JuTU1QSkFLazFPZ0RoUTRuSmphblRDd1pXdFRFUzJOeXRBejBVTWxRN2lXYks0UnQzQ2c5NjFZNzdmSE5ST24zWklSNnl3Q193YmNSd21SQQ?oc=5</link><guid isPermaLink="false">CBMingFBVV95cUxPX3RRWDZjZWQwUHNVdDBlRjlOZnl1MkNQV09WUTlGVXZ3VVN5U2ZRNk9IRFhIYmJfcnZCTW5JUnRkMnc3RWlXbHQzUVo2M3JuTU1QSkFLazFPZ0RoUTRuSmphblRDd1pXdFRFUzJOeXRBejBVTWxRN2lXYks0UnQzQ2c5NjFZNzdmSE5ST24zWklSNnl3Q193YmNSd21SQQ</guid><pubDate>Tue, 21 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPX3RRWDZjZWQwUHNVdDBlRjlOZnl1MkNQV09WUTlGVXZ3VVN5U2ZRNk9IRFhIYmJfcnZCTW5JUnRkMnc3RWlXbHQzUVo2M3JuTU1QSkFLazFPZ0RoUTRuSmphblRDd1pXdFRFUzJOeXRBejBVTWxRN2lXYks0UnQzQ2c5NjFZNzdmSE5ST24zWklSNnl3Q193YmNSd21SQQ?oc=5" target="_blank"&gt;Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;WSJ&lt;/font&gt;</description><source url="https://www.wsj.com">WSJ</source></item><item><title>Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program - Fierce Biotech</title><link>https://news.google.com/rss/articles/CBMisgFBVV95cUxOMm53WVg0eURxM0dVbEhzdDlRb2RNeGE1OWs0b0tmNEZRQjFoMmhhdFZyWi1FaDhQakJmWFZlY2RRazFBSEFfMklOeUFuX0llNHJsS1lvYVpMQXNaUEphVk5DNXpiU3lWZ2VpOE4zZUhFSlk5UXJ0MXBIelRrYU9BUjV3X1k4RXlnaFZ2dk1JTFM4NnZkZ29yRW9ra0FxZjdoWnlUNWFTdnNmRDhvS1U5Si13?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxOMm53WVg0eURxM0dVbEhzdDlRb2RNeGE1OWs0b0tmNEZRQjFoMmhhdFZyWi1FaDhQakJmWFZlY2RRazFBSEFfMklOeUFuX0llNHJsS1lvYVpMQXNaUEphVk5DNXpiU3lWZ2VpOE4zZUhFSlk5UXJ0MXBIelRrYU9BUjV3X1k4RXlnaFZ2dk1JTFM4NnZkZ29yRW9ra0FxZjdoWnlUNWFTdnNmRDhvS1U5Si13</guid><pubDate>Wed, 04 Dec 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOMm53WVg0eURxM0dVbEhzdDlRb2RNeGE1OWs0b0tmNEZRQjFoMmhhdFZyWi1FaDhQakJmWFZlY2RRazFBSEFfMklOeUFuX0llNHJsS1lvYVpMQXNaUEphVk5DNXpiU3lWZ2VpOE4zZUhFSlk5UXJ0MXBIelRrYU9BUjV3X1k4RXlnaFZ2dk1JTFM4NnZkZ29yRW9ra0FxZjdoWnlUNWFTdnNmRDhvS1U5Si13?oc=5" target="_blank"&gt;Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Biotech&lt;/font&gt;</description><source url="https://www.fiercebiotech.com">Fierce Biotech</source></item><item><title>Mitsubishi Tanabe Pharma transforms operation in cloud security powered by Azure OpenAI - Microsoft</title><link>https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNmhiNkRGUkZmZjY3cXlWYjk4Q3Q0ZkRzcy1HX1gtU2xBamlmSmV4U2dhUl94djNTbXpGTHBaWWdmNWdyLXM3Szc0WjF4ci1CcmItSmpXTFhOQkxMb0RrM01BV1pSa09MTFJoalhzT2h1MDFpTHpwbU9HYjZaZC10MUhkcFVheF96QmM2dG1LSmlRWllMWVRDcnJKOGtaN2JacE42U19Bd18?oc=5</link><guid isPermaLink="false">CBMiqAFBVV95cUxNNmhiNkRGUkZmZjY3cXlWYjk4Q3Q0ZkRzcy1HX1gtU2xBamlmSmV4U2dhUl94djNTbXpGTHBaWWdmNWdyLXM3Szc0WjF4ci1CcmItSmpXTFhOQkxMb0RrM01BV1pSa09MTFJoalhzT2h1MDFpTHpwbU9HYjZaZC10MUhkcFVheF96QmM2dG1LSmlRWllMWVRDcnJKOGtaN2JacE42U19Bd18</guid><pubDate>Wed, 01 May 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNmhiNkRGUkZmZjY3cXlWYjk4Q3Q0ZkRzcy1HX1gtU2xBamlmSmV4U2dhUl94djNTbXpGTHBaWWdmNWdyLXM3Szc0WjF4ci1CcmItSmpXTFhOQkxMb0RrM01BV1pSa09MTFJoalhzT2h1MDFpTHpwbU9HYjZaZC10MUhkcFVheF96QmM2dG1LSmlRWllMWVRDcnJKOGtaN2JacE42U19Bd18?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma transforms operation in cloud security powered by Azure OpenAI&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Microsoft&lt;/font&gt;</description><source url="https://www.microsoft.com">Microsoft</source></item><item><title>Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Contract Pharma</title><link>https://news.google.com/rss/articles/CBMiqgFBVV95cUxONGRPTV9oTEp3eXQtTGlTeHVYMVQzaFN1S3BOTVZiZW9oWjViUDJHTjFBOVNuN1pXTGN3Q1VjSWdzSEl5RUV6d2ZydUlOVS1XUWptcnZVUWU2NFV1M1JZQ0MtZ2I3cVlpUC1fU2Z4eXlCakcteU1RRnZMbDRKcnlIYV9EUXFXQU94UnJpekRrUm9ENHk1YnowczFfbi1mWkd5XzZYeTY1T3NIQQ?oc=5</link><guid isPermaLink="false">CBMiqgFBVV95cUxONGRPTV9oTEp3eXQtTGlTeHVYMVQzaFN1S3BOTVZiZW9oWjViUDJHTjFBOVNuN1pXTGN3Q1VjSWdzSEl5RUV6d2ZydUlOVS1XUWptcnZVUWU2NFV1M1JZQ0MtZ2I3cVlpUC1fU2Z4eXlCakcteU1RRnZMbDRKcnlIYV9EUXFXQU94UnJpekRrUm9ENHk1YnowczFfbi1mWkd5XzZYeTY1T3NIQQ</guid><pubDate>Mon, 10 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxONGRPTV9oTEp3eXQtTGlTeHVYMVQzaFN1S3BOTVZiZW9oWjViUDJHTjFBOVNuN1pXTGN3Q1VjSWdzSEl5RUV6d2ZydUlOVS1XUWptcnZVUWU2NFV1M1JZQ0MtZ2I3cVlpUC1fU2Z4eXlCakcteU1RRnZMbDRKcnlIYV9EUXFXQU94UnJpekRrUm9ENHk1YnowczFfbi1mWkd5XzZYeTY1T3NIQQ?oc=5" target="_blank"&gt;Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Contract Pharma&lt;/font&gt;</description><source url="https://www.contractpharma.com">Contract Pharma</source></item><item><title>Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion - Reuters</title><link>https://news.google.com/rss/articles/CBMiwgFBVV95cUxQNG5BXzNZeUlnOWpNVl9tNmhCZlhqRkQ1bHBOLXBOVHJLaUNsWUtIbFNXZGxzOVVBOFIwakd0eEVhSWlSTERSQlFsYUZ3NU5qZGlSZVhDbWdRZ0JNbUF3Q2dNUG5OZ3VqSHEwSEZjS0NocjBUa1hpazRPbmpEb196aUpzdkdQVVV1ZXpZb1pydk5rZHVjNGVKMVhyb1FPUmU3VUdIeHpxc0dwUTQ0amZYWTExUDhsS19MSk5idkpKVDV1Zw?oc=5</link><guid isPermaLink="false">CBMiwgFBVV95cUxQNG5BXzNZeUlnOWpNVl9tNmhCZlhqRkQ1bHBOLXBOVHJLaUNsWUtIbFNXZGxzOVVBOFIwakd0eEVhSWlSTERSQlFsYUZ3NU5qZGlSZVhDbWdRZ0JNbUF3Q2dNUG5OZ3VqSHEwSEZjS0NocjBUa1hpazRPbmpEb196aUpzdkdQVVV1ZXpZb1pydk5rZHVjNGVKMVhyb1FPUmU3VUdIeHpxc0dwUTQ0amZYWTExUDhsS19MSk5idkpKVDV1Zw</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQNG5BXzNZeUlnOWpNVl9tNmhCZlhqRkQ1bHBOLXBOVHJLaUNsWUtIbFNXZGxzOVVBOFIwakd0eEVhSWlSTERSQlFsYUZ3NU5qZGlSZVhDbWdRZ0JNbUF3Q2dNUG5OZ3VqSHEwSEZjS0NocjBUa1hpazRPbmpEb196aUpzdkdQVVV1ZXpZb1pydk5rZHVjNGVKMVhyb1FPUmU3VUdIeHpxc0dwUTQ0amZYWTExUDhsS19MSk5idkpKVDV1Zw?oc=5" target="_blank"&gt;Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;</description><source url="https://www.reuters.com">Reuters</source></item><item><title>New owner for Mitsubishi Tanabe Pharma - The Pharma Letter</title><link>https://news.google.com/rss/articles/CBMiigFBVV95cUxQX2prQ0Q2cmg5dy03M2FZaEJpcTMwYTNPWHl5dTRpWncxdEtXYnNSXzJoTDBnSEFuemtyZEtxV3JfRU1HMTNOdV9EYTJmSXFKRjEwY3dISjhZUnNRWnlmcFVfUVpJZWU5SG9DM241dHAyY1VRa1Y4ZU5wQ3kwMDEtcUlHd0tSeTBiTVE?oc=5</link><guid isPermaLink="false">CBMiigFBVV95cUxQX2prQ0Q2cmg5dy03M2FZaEJpcTMwYTNPWHl5dTRpWncxdEtXYnNSXzJoTDBnSEFuemtyZEtxV3JfRU1HMTNOdV9EYTJmSXFKRjEwY3dISjhZUnNRWnlmcFVfUVpJZWU5SG9DM241dHAyY1VRa1Y4ZU5wQ3kwMDEtcUlHd0tSeTBiTVE</guid><pubDate>Wed, 02 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQX2prQ0Q2cmg5dy03M2FZaEJpcTMwYTNPWHl5dTRpWncxdEtXYnNSXzJoTDBnSEFuemtyZEtxV3JfRU1HMTNOdV9EYTJmSXFKRjEwY3dISjhZUnNRWnlmcFVfUVpJZWU5SG9DM241dHAyY1VRa1Y4ZU5wQ3kwMDEtcUlHd0tSeTBiTVE?oc=5" target="_blank"&gt;New owner for Mitsubishi Tanabe Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Pharma Letter&lt;/font&gt;</description><source url="https://www.thepharmaletter.com">The Pharma Letter</source></item><item><title>Bain To Acquire Mitsubishi Tanabe In $3.4bn Deal - Citeline News &amp; Insights</title><link>https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcmxFNEZlbkdBcmoxVVVOMFVRNmV6X0NoVnRVVzlEYVN0djUtbVh6Um9UaTlTNkNMMTJGVTF6alZSRlhJazF2WnVCT1U5NlMyQnhRN3pZRWx4c3F4WVZGVXd0X2ZqRmZMSy0yYUt1OTNReS1WNTVJa0hRVVJ4c3FjQnMxUmJYYklVX18ybEJZb3ZCVGEzNndVb01kVlBaejZiZlNWcDJDaVVzSExxYkkyQW1xUU5pZ1U3VUdxQWZpTUt3Qzg?oc=5</link><guid isPermaLink="false">CBMiwwFBVV95cUxPcmxFNEZlbkdBcmoxVVVOMFVRNmV6X0NoVnRVVzlEYVN0djUtbVh6Um9UaTlTNkNMMTJGVTF6alZSRlhJazF2WnVCT1U5NlMyQnhRN3pZRWx4c3F4WVZGVXd0X2ZqRmZMSy0yYUt1OTNReS1WNTVJa0hRVVJ4c3FjQnMxUmJYYklVX18ybEJZb3ZCVGEzNndVb01kVlBaejZiZlNWcDJDaVVzSExxYkkyQW1xUU5pZ1U3VUdxQWZpTUt3Qzg</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcmxFNEZlbkdBcmoxVVVOMFVRNmV6X0NoVnRVVzlEYVN0djUtbVh6Um9UaTlTNkNMMTJGVTF6alZSRlhJazF2WnVCT1U5NlMyQnhRN3pZRWx4c3F4WVZGVXd0X2ZqRmZMSy0yYUt1OTNReS1WNTVJa0hRVVJ4c3FjQnMxUmJYYklVX18ybEJZb3ZCVGEzNndVb01kVlBaejZiZlNWcDJDaVVzSExxYkkyQW1xUU5pZ1U3VUdxQWZpTUt3Qzg?oc=5" target="_blank"&gt;Bain To Acquire Mitsubishi Tanabe In $3.4bn Deal&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Citeline News &amp; Insights&lt;/font&gt;</description><source url="https://insights.citeline.com">Citeline News &amp; Insights</source></item><item><title>Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community - PR Newswire</title><link>https://news.google.com/rss/articles/CBMixgFBVV95cUxQZVJTODJocmx0c3pIaVpGbmRiNWl2MFFTWlZDcUx2WGJNa2w3dmQtQy13STBsNGcwR2Zqdlk2MDA5MnRzNmFKZG9HNjhLbV9TR3JBV25QZWw4SXZtc2d5bnYySTE2WmN2b1g4cUZQUGE4VTNGdDdKaVJlaGw4TzkwaGZ1WGwwelE2UjRVQkJiNnBZVndrQlJQVFBwMml3MlBjMWMwOWo4dUdhRkVYdE1PMWZNcE9MN3dhSnVwdXRZRTBKVFRNSGc?oc=5</link><guid isPermaLink="false">CBMixgFBVV95cUxQZVJTODJocmx0c3pIaVpGbmRiNWl2MFFTWlZDcUx2WGJNa2w3dmQtQy13STBsNGcwR2Zqdlk2MDA5MnRzNmFKZG9HNjhLbV9TR3JBV25QZWw4SXZtc2d5bnYySTE2WmN2b1g4cUZQUGE4VTNGdDdKaVJlaGw4TzkwaGZ1WGwwelE2UjRVQkJiNnBZVndrQlJQVFBwMml3MlBjMWMwOWo4dUdhRkVYdE1PMWZNcE9MN3dhSnVwdXRZRTBKVFRNSGc</guid><pubDate>Thu, 23 May 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQZVJTODJocmx0c3pIaVpGbmRiNWl2MFFTWlZDcUx2WGJNa2w3dmQtQy13STBsNGcwR2Zqdlk2MDA5MnRzNmFKZG9HNjhLbV9TR3JBV25QZWw4SXZtc2d5bnYySTE2WmN2b1g4cUZQUGE4VTNGdDdKaVJlaGw4TzkwaGZ1WGwwelE2UjRVQkJiNnBZVndrQlJQVFBwMml3MlBjMWMwOWo4dUdhRkVYdE1PMWZNcE9MN3dhSnVwdXRZRTBKVFRNSGc?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan - Pharmaceutical Technology</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxPMDZBVXpuWE1UR3lRN2FhVzE4dXh0STB1QXJxdFJBUzlKZ3Z1NXVTSktrYUdCdkhUeVBzZ1VlOEdjLTlXQ2VRVnNsSmJfRHl4TmFTMFpPY2JVdVNTV25WU2tKVk4tUC1hQjRLTEM3UkY1WDhsY3BDV1pXSGlrUGdHWEh2VlZGWWM?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxPMDZBVXpuWE1UR3lRN2FhVzE4dXh0STB1QXJxdFJBUzlKZ3Z1NXVTSktrYUdCdkhUeVBzZ1VlOEdjLTlXQ2VRVnNsSmJfRHl4TmFTMFpPY2JVdVNTV25WU2tKVk4tUC1hQjRLTEM3UkY1WDhsY3BDV1pXSGlrUGdHWEh2VlZGWWM</guid><pubDate>Tue, 09 Jul 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPMDZBVXpuWE1UR3lRN2FhVzE4dXh0STB1QXJxdFJBUzlKZ3Z1NXVTSktrYUdCdkhUeVBzZ1VlOEdjLTlXQ2VRVnNsSmJfRHl4TmFTMFpPY2JVdVNTV25WU2tKVk4tUC1hQjRLTEM3UkY1WDhsY3BDV1pXSGlrUGdHWEh2VlZGWWM?oc=5" target="_blank"&gt;Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmaceutical Technology&lt;/font&gt;</description><source url="https://www.pharmaceutical-technology.com">Pharmaceutical Technology</source></item><item><title>GV20 Therapeutics Announces Collaboration Agreement with Mitsubishi Tanabe Pharma Corporation to Develop Novel Antibody-Drug Conjugates - PR Newswire</title><link>https://news.google.com/rss/articles/CBMimwJBVV95cUxNWnA5WW5uRVYzc3JWNl8wcUY2VEFFbDlxbnoxd3FrY1IzbGtLY2QyRC1VbXB2Smw4X21KdHhONWVJUmdRdXdhQjVpalk4OE83QWhTVTJVNmVxUEVGVVg3eHlEQXlsTFdLaHhyWkF4aTFlZ2NkVE5Sc25PTGJaOHdYV25rYVVRX3hTQkdrNXdmVGNTN3I5S19SOVdZelJXWmxVb2xOMUh2UDRONGFHN2xJLUh6WlVBeWQ2dzd1Nm9HTUNvZFVKcHRtYm5vOHFmNUJkZGRjTE9ndXB1bkZ2RXNUR1lkYlFHdkc4MldXRnZXdXA4ZXpFQ0l2SWZoYmxWZlpKV0ZSaTNvN2xwa2FqbVNyU2YzR2lFVk44N19B?oc=5</link><guid isPermaLink="false">CBMimwJBVV95cUxNWnA5WW5uRVYzc3JWNl8wcUY2VEFFbDlxbnoxd3FrY1IzbGtLY2QyRC1VbXB2Smw4X21KdHhONWVJUmdRdXdhQjVpalk4OE83QWhTVTJVNmVxUEVGVVg3eHlEQXlsTFdLaHhyWkF4aTFlZ2NkVE5Sc25PTGJaOHdYV25rYVVRX3hTQkdrNXdmVGNTN3I5S19SOVdZelJXWmxVb2xOMUh2UDRONGFHN2xJLUh6WlVBeWQ2dzd1Nm9HTUNvZFVKcHRtYm5vOHFmNUJkZGRjTE9ndXB1bkZ2RXNUR1lkYlFHdkc4MldXRnZXdXA4ZXpFQ0l2SWZoYmxWZlpKV0ZSaTNvN2xwa2FqbVNyU2YzR2lFVk44N19B</guid><pubDate>Wed, 26 Mar 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMimwJBVV95cUxNWnA5WW5uRVYzc3JWNl8wcUY2VEFFbDlxbnoxd3FrY1IzbGtLY2QyRC1VbXB2Smw4X21KdHhONWVJUmdRdXdhQjVpalk4OE83QWhTVTJVNmVxUEVGVVg3eHlEQXlsTFdLaHhyWkF4aTFlZ2NkVE5Sc25PTGJaOHdYV25rYVVRX3hTQkdrNXdmVGNTN3I5S19SOVdZelJXWmxVb2xOMUh2UDRONGFHN2xJLUh6WlVBeWQ2dzd1Nm9HTUNvZFVKcHRtYm5vOHFmNUJkZGRjTE9ndXB1bkZ2RXNUR1lkYlFHdkc4MldXRnZXdXA4ZXpFQ0l2SWZoYmxWZlpKV0ZSaTNvN2xwa2FqbVNyU2YzR2lFVk44N19B?oc=5" target="_blank"&gt;GV20 Therapeutics Announces Collaboration Agreement with Mitsubishi Tanabe Pharma Corporation to Develop Novel Antibody-Drug Conjugates&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Mitsubishi Tanabe Establishes New US Research Facility - ALS News Today</title><link>https://news.google.com/rss/articles/CBMilAFBVV95cUxQSlY4V1F0aGUxRUw3bmRZWHBOQmZqT0V1S0phUWZNLVg3TVlFMGM0eGZwOEJQem03eVBRQTVVeHdjMk1iTF9GQmlycmZmLVIyREtKSFdRVFlmeVBzd2xWenFoU0xMQVJkUEROSFV0SmQ3STFIT2l3eGRNWGV1OU1KM09jODJIUElzNE1sWUJybGUwb0h1?oc=5</link><guid isPermaLink="false">CBMilAFBVV95cUxQSlY4V1F0aGUxRUw3bmRZWHBOQmZqT0V1S0phUWZNLVg3TVlFMGM0eGZwOEJQem03eVBRQTVVeHdjMk1iTF9GQmlycmZmLVIyREtKSFdRVFlmeVBzd2xWenFoU0xMQVJkUEROSFV0SmQ3STFIT2l3eGRNWGV1OU1KM09jODJIUElzNE1sWUJybGUwb0h1</guid><pubDate>Fri, 12 Mar 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQSlY4V1F0aGUxRUw3bmRZWHBOQmZqT0V1S0phUWZNLVg3TVlFMGM0eGZwOEJQem03eVBRQTVVeHdjMk1iTF9GQmlycmZmLVIyREtKSFdRVFlmeVBzd2xWenFoU0xMQVJkUEROSFV0SmQ3STFIT2l3eGRNWGV1OU1KM09jODJIUElzNE1sWUJybGUwb0h1?oc=5" target="_blank"&gt;Mitsubishi Tanabe Establishes New US Research Facility&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;ALS News Today&lt;/font&gt;</description><source url="https://alsnewstoday.com">ALS News Today</source></item><item><title>Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase' - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMirwFBVV95cUxQZ1NjT1JINzBQUDE0MmV5SHBaaTNXQXFKa3J1SUtPbzNDTmY3THhoLXVCdUpnTTdwcUpVaVI4UF9EZFZ4Um5DT1VLcFRxbk5DdmlXYjB6d29UNWRHaElIM2NVT19hQjZxMnMxSlZmbGhNaGFnQjEzd3lINGVWaV9nNXBQOEpJZFJ3MmZSZHRfRHRjNVZhZzJJcEpYMHRZamQ2NFI5TzBZV0lhYnJJVDNZ?oc=5</link><guid isPermaLink="false">CBMirwFBVV95cUxQZ1NjT1JINzBQUDE0MmV5SHBaaTNXQXFKa3J1SUtPbzNDTmY3THhoLXVCdUpnTTdwcUpVaVI4UF9EZFZ4Um5DT1VLcFRxbk5DdmlXYjB6d29UNWRHaElIM2NVT19hQjZxMnMxSlZmbGhNaGFnQjEzd3lINGVWaV9nNXBQOEpJZFJ3MmZSZHRfRHRjNVZhZzJJcEpYMHRZamQ2NFI5TzBZV0lhYnJJVDNZ</guid><pubDate>Fri, 14 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQZ1NjT1JINzBQUDE0MmV5SHBaaTNXQXFKa3J1SUtPbzNDTmY3THhoLXVCdUpnTTdwcUpVaVI4UF9EZFZ4Um5DT1VLcFRxbk5DdmlXYjB6d29UNWRHaElIM2NVT19hQjZxMnMxSlZmbGhNaGFnQjEzd3lINGVWaV9nNXBQOEpJZFJ3MmZSZHRfRHRjNVZhZzJJcEpYMHRZamQ2NFI5TzBZV0lhYnJJVDNZ?oc=5" target="_blank"&gt;Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Martin Pharmaceuticals Secures Exclusive Rights From Mitsubishi Tanabe Pharma for Docarpamine to Treat Decompensated Chronic Liver Disease Including Ascites - PR Newswire</title><link>https://news.google.com/rss/articles/CBMitwJBVV95cUxNT0NxcUtHR3JKZ0dfU2x4WGZ0UTRpSTRuRXJGVVF3VEtnSlc2NmdXc1JzaHo4aDQ3SXVaRV9zcUNxbFp0cHRmZ2VSMC1BU0NUZkZmLXdlRW93dURTaDV4RXlUVy1lcERaZDBvMzZBZDk3bW5GWHZ5eC1ZLW1WNXJVeG5NTzNMeVFMbklfeVZiVU42aXltUG84aHlzU0VfV2QyWnREX2xFQWVRVjBJSk1fTlI5Z1ZlTFlJdHlLY2J3U2RlZXRDNXdtTDdtQ09JaHU0OUo3MnN0NUNOenY3YTBLcDlKY0wxdjItZC0zZ0ZIVTY2czBGaWFoTzdDODhNMkxvUVQxVnVsLWlfWWlZSEc1QVdOcDdIX2hDQWZMVGFIQVYwVUJPclBmalRBR2hqeDZSMUg3YUdCZw?oc=5</link><guid isPermaLink="false">CBMitwJBVV95cUxNT0NxcUtHR3JKZ0dfU2x4WGZ0UTRpSTRuRXJGVVF3VEtnSlc2NmdXc1JzaHo4aDQ3SXVaRV9zcUNxbFp0cHRmZ2VSMC1BU0NUZkZmLXdlRW93dURTaDV4RXlUVy1lcERaZDBvMzZBZDk3bW5GWHZ5eC1ZLW1WNXJVeG5NTzNMeVFMbklfeVZiVU42aXltUG84aHlzU0VfV2QyWnREX2xFQWVRVjBJSk1fTlI5Z1ZlTFlJdHlLY2J3U2RlZXRDNXdtTDdtQ09JaHU0OUo3MnN0NUNOenY3YTBLcDlKY0wxdjItZC0zZ0ZIVTY2czBGaWFoTzdDODhNMkxvUVQxVnVsLWlfWWlZSEc1QVdOcDdIX2hDQWZMVGFIQVYwVUJPclBmalRBR2hqeDZSMUg3YUdCZw</guid><pubDate>Tue, 03 Dec 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMitwJBVV95cUxNT0NxcUtHR3JKZ0dfU2x4WGZ0UTRpSTRuRXJGVVF3VEtnSlc2NmdXc1JzaHo4aDQ3SXVaRV9zcUNxbFp0cHRmZ2VSMC1BU0NUZkZmLXdlRW93dURTaDV4RXlUVy1lcERaZDBvMzZBZDk3bW5GWHZ5eC1ZLW1WNXJVeG5NTzNMeVFMbklfeVZiVU42aXltUG84aHlzU0VfV2QyWnREX2xFQWVRVjBJSk1fTlI5Z1ZlTFlJdHlLY2J3U2RlZXRDNXdtTDdtQ09JaHU0OUo3MnN0NUNOenY3YTBLcDlKY0wxdjItZC0zZ0ZIVTY2czBGaWFoTzdDODhNMkxvUVQxVnVsLWlfWWlZSEc1QVdOcDdIX2hDQWZMVGFIQVYwVUJPclBmalRBR2hqeDZSMUg3YUdCZw?oc=5" target="_blank"&gt;Martin Pharmaceuticals Secures Exclusive Rights From Mitsubishi Tanabe Pharma for Docarpamine to Treat Decompensated Chronic Liver Disease Including Ascites&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>GV20 Therapeutics Announces Achievement of Milestone under Antibody-Drug Conjugate Collaboration with Mitsubishi Tanabe Pharma Corporation - PR Newswire</title><link>https://news.google.com/rss/articles/CBMinwJBVV95cUxPcjFscERKc1ZZN0tnTjQwRVNWcm9icGZud1FQNzR3TUpQMWNnRFRRTjN4QkRVQjNBVGlKYWNvUjE2Tnd0dnhLeks3ZlBIbVRPRVhFRHJJbTRqRndNRUt0Q1RXYVlaUWFoLUw2bll6QUhFeHBJcUhxVUEtcTBhZVFXT2VrcThKazRvQ2ZJVy0wLXhHczhvaGVSRVlKM1kzcXJPRENlNVA5eDA2ZVVSMmkyclRpUXh5aWt3aUZ1a3hYdUtkYTlxbWdtRkd0ZUQ4TjkzOWhDYy1nSnJ5TFhMNnFBWm12blpZY2U5M3BFbnZ3U3AxczlHV1JzZlRmbDZVLWF4V2o4Ny1NWWxfcHIyNmtORXFveURtRXQ3UVVkSDBZSQ?oc=5</link><guid isPermaLink="false">CBMinwJBVV95cUxPcjFscERKc1ZZN0tnTjQwRVNWcm9icGZud1FQNzR3TUpQMWNnRFRRTjN4QkRVQjNBVGlKYWNvUjE2Tnd0dnhLeks3ZlBIbVRPRVhFRHJJbTRqRndNRUt0Q1RXYVlaUWFoLUw2bll6QUhFeHBJcUhxVUEtcTBhZVFXT2VrcThKazRvQ2ZJVy0wLXhHczhvaGVSRVlKM1kzcXJPRENlNVA5eDA2ZVVSMmkyclRpUXh5aWt3aUZ1a3hYdUtkYTlxbWdtRkd0ZUQ4TjkzOWhDYy1nSnJ5TFhMNnFBWm12blpZY2U5M3BFbnZ3U3AxczlHV1JzZlRmbDZVLWF4V2o4Ny1NWWxfcHIyNmtORXFveURtRXQ3UVVkSDBZSQ</guid><pubDate>Tue, 25 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMinwJBVV95cUxPcjFscERKc1ZZN0tnTjQwRVNWcm9icGZud1FQNzR3TUpQMWNnRFRRTjN4QkRVQjNBVGlKYWNvUjE2Tnd0dnhLeks3ZlBIbVRPRVhFRHJJbTRqRndNRUt0Q1RXYVlaUWFoLUw2bll6QUhFeHBJcUhxVUEtcTBhZVFXT2VrcThKazRvQ2ZJVy0wLXhHczhvaGVSRVlKM1kzcXJPRENlNVA5eDA2ZVVSMmkyclRpUXh5aWt3aUZ1a3hYdUtkYTlxbWdtRkd0ZUQ4TjkzOWhDYy1nSnJ5TFhMNnFBWm12blpZY2U5M3BFbnZ3U3AxczlHV1JzZlRmbDZVLWF4V2o4Ny1NWWxfcHIyNmtORXFveURtRXQ3UVVkSDBZSQ?oc=5" target="_blank"&gt;GV20 Therapeutics Announces Achievement of Milestone under Antibody-Drug Conjugate Collaboration with Mitsubishi Tanabe Pharma Corporation&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma - MedCity News</title><link>https://news.google.com/rss/articles/CBMisgFBVV95cUxQQXNjaTRiQmVFaFBweFI4R20yeWROaU45NmExSDJ3bXhNZEdneUdqNXA0NG1NS2JJUWJ4eDFjelhNWldKQjVxWUNaa1ljRUFESWNnSnU1RkRXblhaQ3IyS2gzbjEtSWNXWlA1aFZ5SHdZYlFNYVpJNTF6b0JMakJHTUFTTGV5eXlpWTlaV3k0TzBLYkxkOEVWdXloMjlkMERkUXhpNDEteW5OVnh6NWF0SmZR?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxQQXNjaTRiQmVFaFBweFI4R20yeWROaU45NmExSDJ3bXhNZEdneUdqNXA0NG1NS2JJUWJ4eDFjelhNWldKQjVxWUNaa1ljRUFESWNnSnU1RkRXblhaQ3IyS2gzbjEtSWNXWlA1aFZ5SHdZYlFNYVpJNTF6b0JMakJHTUFTTGV5eXlpWTlaV3k0TzBLYkxkOEVWdXloMjlkMERkUXhpNDEteW5OVnh6NWF0SmZR</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQQXNjaTRiQmVFaFBweFI4R20yeWROaU45NmExSDJ3bXhNZEdneUdqNXA0NG1NS2JJUWJ4eDFjelhNWldKQjVxWUNaa1ljRUFESWNnSnU1RkRXblhaQ3IyS2gzbjEtSWNXWlA1aFZ5SHdZYlFNYVpJNTF6b0JMakJHTUFTTGV5eXlpWTlaV3k0TzBLYkxkOEVWdXloMjlkMERkUXhpNDEteW5OVnh6NWF0SmZR?oc=5" target="_blank"&gt;Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MedCity News&lt;/font&gt;</description><source url="https://medcitynews.com">MedCity News</source></item><item><title>Japan's Oldest Pharma Firm to Be Sold to Bain Capital - JAPAN Forward</title><link>https://news.google.com/rss/articles/CBMihgFBVV95cUxPc2g0MFFBZk9IVjg5OG1mdy1xODN3dlBVdjRPZGctN2x0b1Zta3Q3Xy1HVFBURmN0TkpkVnFFSFdVbXhhR3F5WGVWUi1XeE45RFAweUsxaTdlN1hJbVdSYjJEb3RKOWw4QTF3SlFtaVF0WVRuSHlscW1WRGVEZXJhaW8tVnhWUQ?oc=5</link><guid isPermaLink="false">CBMihgFBVV95cUxPc2g0MFFBZk9IVjg5OG1mdy1xODN3dlBVdjRPZGctN2x0b1Zta3Q3Xy1HVFBURmN0TkpkVnFFSFdVbXhhR3F5WGVWUi1XeE45RFAweUsxaTdlN1hJbVdSYjJEb3RKOWw4QTF3SlFtaVF0WVRuSHlscW1WRGVEZXJhaW8tVnhWUQ</guid><pubDate>Fri, 13 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxPc2g0MFFBZk9IVjg5OG1mdy1xODN3dlBVdjRPZGctN2x0b1Zta3Q3Xy1HVFBURmN0TkpkVnFFSFdVbXhhR3F5WGVWUi1XeE45RFAweUsxaTdlN1hJbVdSYjJEb3RKOWw4QTF3SlFtaVF0WVRuSHlscW1WRGVEZXJhaW8tVnhWUQ?oc=5" target="_blank"&gt;Japan's Oldest Pharma Firm to Be Sold to Bain Capital&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;JAPAN Forward&lt;/font&gt;</description><source url="https://japan-forward.com">JAPAN Forward</source></item><item><title>Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn - pharmaphorum</title><link>https://news.google.com/rss/articles/CBMihAFBVV95cUxPdVM2Qk8wbXlqRzJmekJOWkJQdzJRUnNwQjZaTzd5Y0dKZDRoSzIxeUQ2NVNhU2dpRnM3U0dDcEhxUlhXd1RyM05DckRlWUlIMURjWGUxNDJES0tjNlNSZi1yR085VFBvOEdaWHltZm1oOWhDSHlOOW15SExXNjVpZXhrTWM?oc=5</link><guid isPermaLink="false">CBMihAFBVV95cUxPdVM2Qk8wbXlqRzJmekJOWkJQdzJRUnNwQjZaTzd5Y0dKZDRoSzIxeUQ2NVNhU2dpRnM3U0dDcEhxUlhXd1RyM05DckRlWUlIMURjWGUxNDJES0tjNlNSZi1yR085VFBvOEdaWHltZm1oOWhDSHlOOW15SExXNjVpZXhrTWM</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPdVM2Qk8wbXlqRzJmekJOWkJQdzJRUnNwQjZaTzd5Y0dKZDRoSzIxeUQ2NVNhU2dpRnM3U0dDcEhxUlhXd1RyM05DckRlWUlIMURjWGUxNDJES0tjNlNSZi1yR085VFBvOEdaWHltZm1oOWhDSHlOOW15SExXNjVpZXhrTWM?oc=5" target="_blank"&gt;Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;pharmaphorum&lt;/font&gt;</description><source url="https://pharmaphorum.com">pharmaphorum</source></item><item><title>Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe - Pharmaceutical Technology</title><link>https://news.google.com/rss/articles/CBMisgFBVV95cUxONEVlOXRENzBfaWZFaEpOdjBKSUNCWEI4elJPdFpwdVd2YzkyMXRsUmhzUDA0VGM5Vnl5SEJDeWROMlJfbGUtdjVuWWF0WTlIOUNnel9LZURodVkxT0VHUE5Fc0dtSTRIMEJleHlQZTM0LV9QTERld0RheDJ6N19KLUNzc1AwMlYycHhkWk5wZ1ppek5MdFhFOVJpOGdiUGxFUVkzcG5KM1FfcEg5NUFIWDhR?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxONEVlOXRENzBfaWZFaEpOdjBKSUNCWEI4elJPdFpwdVd2YzkyMXRsUmhzUDA0VGM5Vnl5SEJDeWROMlJfbGUtdjVuWWF0WTlIOUNnel9LZURodVkxT0VHUE5Fc0dtSTRIMEJleHlQZTM0LV9QTERld0RheDJ6N19KLUNzc1AwMlYycHhkWk5wZ1ppek5MdFhFOVJpOGdiUGxFUVkzcG5KM1FfcEg5NUFIWDhR</guid><pubDate>Fri, 10 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxONEVlOXRENzBfaWZFaEpOdjBKSUNCWEI4elJPdFpwdVd2YzkyMXRsUmhzUDA0VGM5Vnl5SEJDeWROMlJfbGUtdjVuWWF0WTlIOUNnel9LZURodVkxT0VHUE5Fc0dtSTRIMEJleHlQZTM0LV9QTERld0RheDJ6N19KLUNzc1AwMlYycHhkWk5wZ1ppek5MdFhFOVJpOGdiUGxFUVkzcG5KM1FfcEg5NUFIWDhR?oc=5" target="_blank"&gt;Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmaceutical Technology&lt;/font&gt;</description><source url="https://www.pharmaceutical-technology.com">Pharmaceutical Technology</source></item><item><title>Bain Capital to Buy Mitsubishi Tanabe Pharma Corporation - citybiz</title><link>https://news.google.com/rss/articles/CBMimwFBVV95cUxQLWV5NkhTamNVU3FSNm1EbEwwMnhXRkpOR1JqNW5JdDJwZTJKMktyMmZhMnlLN2pKR29VRGlfZVluSU9oWWFlc3RZcUdhcG5LNXpaRTVVMGdHS0lISUpuTVgxQWd2a3l1TFBGV0xTNWpIWVdCNE83ajJXbVpicHp2dWN0c1VSdUtRTEU5OGVEWEl3dW4wSUdaRV9Eaw?oc=5</link><guid isPermaLink="false">CBMimwFBVV95cUxQLWV5NkhTamNVU3FSNm1EbEwwMnhXRkpOR1JqNW5JdDJwZTJKMktyMmZhMnlLN2pKR29VRGlfZVluSU9oWWFlc3RZcUdhcG5LNXpaRTVVMGdHS0lISUpuTVgxQWd2a3l1TFBGV0xTNWpIWVdCNE83ajJXbVpicHp2dWN0c1VSdUtRTEU5OGVEWEl3dW4wSUdaRV9Eaw</guid><pubDate>Wed, 12 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQLWV5NkhTamNVU3FSNm1EbEwwMnhXRkpOR1JqNW5JdDJwZTJKMktyMmZhMnlLN2pKR29VRGlfZVluSU9oWWFlc3RZcUdhcG5LNXpaRTVVMGdHS0lISUpuTVgxQWd2a3l1TFBGV0xTNWpIWVdCNE83ajJXbVpicHp2dWN0c1VSdUtRTEU5OGVEWEl3dW4wSUdaRV9Eaw?oc=5" target="_blank"&gt;Bain Capital to Buy Mitsubishi Tanabe Pharma Corporation&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;citybiz&lt;/font&gt;</description><source url="https://www.citybiz.co">citybiz</source></item><item><title>Astrazeneca and Mitsubishi Tanabe Pharma jointly develop NLRP3 inflammasome inhibitors - BioWorld News</title><link>https://news.google.com/rss/articles/CBMixgFBVV95cUxON0RjQWxvUmFkc3lHUEtSTDhxd3BrNzRaVzJteUF4Zmo5UHRaWEhnRTEwR2dyNUJ5OXk1WVNOU1phVjVNQWdaNExqZUhEOFlQOC16aG5OV3lvUkVocDV3cjhQNElqam9tTmxKZ3d1NzVtWF92TENNWEcyYTIzejZ6ZlA5S1lNQUdxM0VFTFBUZmNsZDdHM3M0bzNjTWc0bXVEWTRZb1pQRnNhNmd0SWdiMkhpQ1BmOS1Hd25CY19qUWt0cF84Rnc?oc=5</link><guid isPermaLink="false">CBMixgFBVV95cUxON0RjQWxvUmFkc3lHUEtSTDhxd3BrNzRaVzJteUF4Zmo5UHRaWEhnRTEwR2dyNUJ5OXk1WVNOU1phVjVNQWdaNExqZUhEOFlQOC16aG5OV3lvUkVocDV3cjhQNElqam9tTmxKZ3d1NzVtWF92TENNWEcyYTIzejZ6ZlA5S1lNQUdxM0VFTFBUZmNsZDdHM3M0bzNjTWc0bXVEWTRZb1pQRnNhNmd0SWdiMkhpQ1BmOS1Hd25CY19qUWt0cF84Rnc</guid><pubDate>Wed, 24 Jul 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxON0RjQWxvUmFkc3lHUEtSTDhxd3BrNzRaVzJteUF4Zmo5UHRaWEhnRTEwR2dyNUJ5OXk1WVNOU1phVjVNQWdaNExqZUhEOFlQOC16aG5OV3lvUkVocDV3cjhQNElqam9tTmxKZ3d1NzVtWF92TENNWEcyYTIzejZ6ZlA5S1lNQUdxM0VFTFBUZmNsZDdHM3M0bzNjTWc0bXVEWTRZb1pQRnNhNmd0SWdiMkhpQ1BmOS1Hd25CY19qUWt0cF84Rnc?oc=5" target="_blank"&gt;Astrazeneca and Mitsubishi Tanabe Pharma jointly develop NLRP3 inflammasome inhibitors&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;BioWorld News&lt;/font&gt;</description><source url="https://www.bioworld.com">BioWorld News</source></item><item><title>Biogen Licenses Mitsubishi Tanabe Pharma’s Phase 2 Molecule for Autoimmune Diseases - Biogen</title><link>https://news.google.com/rss/articles/CBMivwFBVV95cUxPWTRfeXZHVjZVRWhoZnFNWUM0bDB3MkNLaU53N1FJb2tIQ0gzbUdQV3pEeHhjTF9TbWU1Z3U0Ykx2bHV1NWFYajB1N1M2bnNrMmJUMnpqTDY3OVNka2ZFWTA2eVNnYXJqd0NPVXBWa3VfQzBnOU1DRE85QWNUbGRZOGw0T0NpdHp5WnZYbGpxdGtPNDNMNlpzSWgzTklPNEQxXzcxZjkwelFoZDJmMDVEc2Rfc2xCU0Jhd0VCMGI1QQ?oc=5</link><guid isPermaLink="false">CBMivwFBVV95cUxPWTRfeXZHVjZVRWhoZnFNWUM0bDB3MkNLaU53N1FJb2tIQ0gzbUdQV3pEeHhjTF9TbWU1Z3U0Ykx2bHV1NWFYajB1N1M2bnNrMmJUMnpqTDY3OVNka2ZFWTA2eVNnYXJqd0NPVXBWa3VfQzBnOU1DRE85QWNUbGRZOGw0T0NpdHp5WnZYbGpxdGtPNDNMNlpzSWgzTklPNEQxXzcxZjkwelFoZDJmMDVEc2Rfc2xCU0Jhd0VCMGI1QQ</guid><pubDate>Wed, 09 Sep 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPWTRfeXZHVjZVRWhoZnFNWUM0bDB3MkNLaU53N1FJb2tIQ0gzbUdQV3pEeHhjTF9TbWU1Z3U0Ykx2bHV1NWFYajB1N1M2bnNrMmJUMnpqTDY3OVNka2ZFWTA2eVNnYXJqd0NPVXBWa3VfQzBnOU1DRE85QWNUbGRZOGw0T0NpdHp5WnZYbGpxdGtPNDNMNlpzSWgzTklPNEQxXzcxZjkwelFoZDJmMDVEc2Rfc2xCU0Jhd0VCMGI1QQ?oc=5" target="_blank"&gt;Biogen Licenses Mitsubishi Tanabe Pharma’s Phase 2 Molecule for Autoimmune Diseases&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Biogen&lt;/font&gt;</description><source url="https://investors.biogen.com">Biogen</source></item><item><title>Japan's Mitsubishi Tanabe and EditForce sign $146M deal to discover CNS gene therapies - Fierce Biotech</title><link>https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMUhoSG9fMXRQUWxWbFNxNGsySm9BWVNhWHJXRXJEdXhLd1RyWF9qdGlsOWpQNERTWmxoaTc4UWNwa0t5b056Ymxxem9Sc3EwRzhXYTlkU2pmclJBUTFNSkxjR1hIUDRKWXZ4TUNNX0FVVjJTNWd3Q0tXLVF4dTJDVFBpcjlWUXVGdG00RXR6NlMxRnBRbDVOalB1TU4xN2NWNjBCZlh0NHc5dTA3UEhZWmhXZzlNcTAyTVFB?oc=5</link><guid isPermaLink="false">CBMiuwFBVV95cUxOMUhoSG9fMXRQUWxWbFNxNGsySm9BWVNhWHJXRXJEdXhLd1RyWF9qdGlsOWpQNERTWmxoaTc4UWNwa0t5b056Ymxxem9Sc3EwRzhXYTlkU2pmclJBUTFNSkxjR1hIUDRKWXZ4TUNNX0FVVjJTNWd3Q0tXLVF4dTJDVFBpcjlWUXVGdG00RXR6NlMxRnBRbDVOalB1TU4xN2NWNjBCZlh0NHc5dTA3UEhZWmhXZzlNcTAyTVFB</guid><pubDate>Tue, 05 Jul 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMUhoSG9fMXRQUWxWbFNxNGsySm9BWVNhWHJXRXJEdXhLd1RyWF9qdGlsOWpQNERTWmxoaTc4UWNwa0t5b056Ymxxem9Sc3EwRzhXYTlkU2pmclJBUTFNSkxjR1hIUDRKWXZ4TUNNX0FVVjJTNWd3Q0tXLVF4dTJDVFBpcjlWUXVGdG00RXR6NlMxRnBRbDVOalB1TU4xN2NWNjBCZlh0NHc5dTA3UEhZWmhXZzlNcTAyTVFB?oc=5" target="_blank"&gt;Japan's Mitsubishi Tanabe and EditForce sign $146M deal to discover CNS gene therapies&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Biotech&lt;/font&gt;</description><source url="https://www.fiercebiotech.com">Fierce Biotech</source></item><item><title>Mitsubishi Tanabe Pharma America Announces EXSERVAN™ (riluzole) is Now Available - MultiVu</title><link>https://news.google.com/rss/articles/CBMipgFBVV95cUxNN1dtcFJtVnJ4TmhuZXVVZzZQME9iWEhILS1aRklvQ3g3MFR4WmlGaHpTU3ZxRDl4TXN4Yng4Y3pSYm5paDNGVVVydnVSWHhadHhzU3ZuSm9jUzh1c2hWdkFLSnk0Ylh1d2FzX01IT0R4a19jSF9GOHRBNzFsbGZrMzBvRXZPd2E5QXgxZHpyRklkM3M0U1ZHN0NpejlNZlNpV25rbUpn?oc=5</link><guid isPermaLink="false">CBMipgFBVV95cUxNN1dtcFJtVnJ4TmhuZXVVZzZQME9iWEhILS1aRklvQ3g3MFR4WmlGaHpTU3ZxRDl4TXN4Yng4Y3pSYm5paDNGVVVydnVSWHhadHhzU3ZuSm9jUzh1c2hWdkFLSnk0Ylh1d2FzX01IT0R4a19jSF9GOHRBNzFsbGZrMzBvRXZPd2E5QXgxZHpyRklkM3M0U1ZHN0NpejlNZlNpV25rbUpn</guid><pubDate>Sun, 01 Aug 2021 11:58:54 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNN1dtcFJtVnJ4TmhuZXVVZzZQME9iWEhILS1aRklvQ3g3MFR4WmlGaHpTU3ZxRDl4TXN4Yng4Y3pSYm5paDNGVVVydnVSWHhadHhzU3ZuSm9jUzh1c2hWdkFLSnk0Ylh1d2FzX01IT0R4a19jSF9GOHRBNzFsbGZrMzBvRXZPd2E5QXgxZHpyRklkM3M0U1ZHN0NpejlNZlNpV25rbUpn?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America Announces EXSERVAN™ (riluzole) is Now Available&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MultiVu&lt;/font&gt;</description><source url="https://www.multivu.com">MultiVu</source></item><item><title>Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal - The Japan Times</title><link>https://news.google.com/rss/articles/CBMiogFBVV95cUxPeXpyTUR2Tm01aWhaSXE0SHZSZ2M1SXRJOExLd0F4R0VzNGFTTUtBRmh0SzFmZ1dXVXR5c2tGNDRpSG0tQlR0LVZtLWZsNGU2UUlreGwwUkM5UG50WW1NemFOTzUwYTk5c2lodlZBOVhZQi1mSlppMG56djFPbVZfZXp2VUdxQWNnR0o3UFk1X2phaVctbjZ2RlEtdnVzcmphVVE?oc=5</link><guid isPermaLink="false">CBMiogFBVV95cUxPeXpyTUR2Tm01aWhaSXE0SHZSZ2M1SXRJOExLd0F4R0VzNGFTTUtBRmh0SzFmZ1dXVXR5c2tGNDRpSG0tQlR0LVZtLWZsNGU2UUlreGwwUkM5UG50WW1NemFOTzUwYTk5c2lodlZBOVhZQi1mSlppMG56djFPbVZfZXp2VUdxQWNnR0o3UFk1X2phaVctbjZ2RlEtdnVzcmphVVE</guid><pubDate>Sun, 09 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPeXpyTUR2Tm01aWhaSXE0SHZSZ2M1SXRJOExLd0F4R0VzNGFTTUtBRmh0SzFmZ1dXVXR5c2tGNDRpSG0tQlR0LVZtLWZsNGU2UUlreGwwUkM5UG50WW1NemFOTzUwYTk5c2lodlZBOVhZQi1mSlppMG56djFPbVZfZXp2VUdxQWNnR0o3UFk1X2phaVctbjZ2RlEtdnVzcmphVVE?oc=5" target="_blank"&gt;Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Japan Times&lt;/font&gt;</description><source url="https://www.japantimes.co.jp">The Japan Times</source></item><item><title>How will Bain Capital's acquisition of Mitsubishi Tanabe Pharma impact Korean operation? - koreabiomed.com</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBfRWhFWms0cTEwejQtYWNzc0lqQUNLTnBWTDA5bzY1NVFSOGVsMDl5aHJkME43ZjQ5TGlPTUFDQnh5MDRfc3NxcW1OYmwyeE0yLW1YT3NvVk9tR3FrWG1fNHBKd2pyd0ZwZExaY2RB0gFyQVVfeXFMTXRzSTAydUczbEthRklORWpsbUU0dDEzVE5CRnE3Y180NV9qWk05eTVyZm1qdW1wWERYTzJrdTRqVTVKVVdWclpYRXduOHBmWVlocWl3WUhJTUVIYXFLUnNyNG1HRDdzTmx6cktrNkxFVzhn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBfRWhFWms0cTEwejQtYWNzc0lqQUNLTnBWTDA5bzY1NVFSOGVsMDl5aHJkME43ZjQ5TGlPTUFDQnh5MDRfc3NxcW1OYmwyeE0yLW1YT3NvVk9tR3FrWG1fNHBKd2pyd0ZwZExaY2RB0gFyQVVfeXFMTXRzSTAydUczbEthRklORWpsbUU0dDEzVE5CRnE3Y180NV9qWk05eTVyZm1qdW1wWERYTzJrdTRqVTVKVVdWclpYRXduOHBmWVlocWl3WUhJTUVIYXFLUnNyNG1HRDdzTmx6cktrNkxFVzhn</guid><pubDate>Tue, 11 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBfRWhFWms0cTEwejQtYWNzc0lqQUNLTnBWTDA5bzY1NVFSOGVsMDl5aHJkME43ZjQ5TGlPTUFDQnh5MDRfc3NxcW1OYmwyeE0yLW1YT3NvVk9tR3FrWG1fNHBKd2pyd0ZwZExaY2RB0gFyQVVfeXFMTXRzSTAydUczbEthRklORWpsbUU0dDEzVE5CRnE3Y180NV9qWk05eTVyZm1qdW1wWERYTzJrdTRqVTVKVVdWclpYRXduOHBmWVlocWl3WUhJTUVIYXFLUnNyNG1HRDdzTmx6cktrNkxFVzhn?oc=5" target="_blank"&gt;How will Bain Capital's acquisition of Mitsubishi Tanabe Pharma impact Korean operation?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;koreabiomed.com&lt;/font&gt;</description><source url="https://www.koreabiomed.com">koreabiomed.com</source></item><item><title>Mitsubishi Tanabe Pharma America Announces Reorganization - citybiz</title><link>https://news.google.com/rss/articles/CBMinAFBVV95cUxNWWdRYWJmZU9qVWczMnpFNXVCY3BmQlRxeUlqMHBaUzM1c1p4ekdwYzRkeXU0eGlLdExQRi1NZkt0NkZnRlI0NzZEdXotZE9VRjE0X2Vvd2l0UFVSYkdNS3NINmltdFpHUVM1UG9xQmdJZzRLcWVOTTVJVU9JVHZCN1Zka1NnOTdELTVJX09tZ2hZSGJDcHVrS05YeEo?oc=5</link><guid isPermaLink="false">CBMinAFBVV95cUxNWWdRYWJmZU9qVWczMnpFNXVCY3BmQlRxeUlqMHBaUzM1c1p4ekdwYzRkeXU0eGlLdExQRi1NZkt0NkZnRlI0NzZEdXotZE9VRjE0X2Vvd2l0UFVSYkdNS3NINmltdFpHUVM1UG9xQmdJZzRLcWVOTTVJVU9JVHZCN1Zka1NnOTdELTVJX09tZ2hZSGJDcHVrS05YeEo</guid><pubDate>Mon, 03 Apr 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNWWdRYWJmZU9qVWczMnpFNXVCY3BmQlRxeUlqMHBaUzM1c1p4ekdwYzRkeXU0eGlLdExQRi1NZkt0NkZnRlI0NzZEdXotZE9VRjE0X2Vvd2l0UFVSYkdNS3NINmltdFpHUVM1UG9xQmdJZzRLcWVOTTVJVU9JVHZCN1Zka1NnOTdELTVJX09tZ2hZSGJDcHVrS05YeEo?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America Announces Reorganization&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;citybiz&lt;/font&gt;</description><source url="https://www.citybiz.co">citybiz</source></item><item><title>Mitsubishi Tanabe pulls Radicava app after skeptical EU regulators ask for new trial - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMivgFBVV95cUxQZFFrMExqVGltamtEOVo4YTNTaHhyZFpBeGVUXzUxWTNGZWVkYlhMaEJhXzBKY1g3NVdySURXdFlJbzNBdGV0V2llVDFZSWF2V2pUQzVweV9RcHFGSnFKZjZuTFBneXhnekdsaWZ0TXFybU9LZkxrRUpqek1TVmhucVVmYUZldkkwUWRVTWxENzBuTzBrT19SUlZ0bW5ZRjl2c01kQkpDeFY4RmNfdXpqcVhsMjZ2TXhkWjZVSDZB?oc=5</link><guid isPermaLink="false">CBMivgFBVV95cUxQZFFrMExqVGltamtEOVo4YTNTaHhyZFpBeGVUXzUxWTNGZWVkYlhMaEJhXzBKY1g3NVdySURXdFlJbzNBdGV0V2llVDFZSWF2V2pUQzVweV9RcHFGSnFKZjZuTFBneXhnekdsaWZ0TXFybU9LZkxrRUpqek1TVmhucVVmYUZldkkwUWRVTWxENzBuTzBrT19SUlZ0bW5ZRjl2c01kQkpDeFY4RmNfdXpqcVhsMjZ2TXhkWjZVSDZB</guid><pubDate>Fri, 31 May 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQZFFrMExqVGltamtEOVo4YTNTaHhyZFpBeGVUXzUxWTNGZWVkYlhMaEJhXzBKY1g3NVdySURXdFlJbzNBdGV0V2llVDFZSWF2V2pUQzVweV9RcHFGSnFKZjZuTFBneXhnekdsaWZ0TXFybU9LZkxrRUpqek1TVmhucVVmYUZldkkwUWRVTWxENzBuTzBrT19SUlZ0bW5ZRjl2c01kQkpDeFY4RmNfdXpqcVhsMjZ2TXhkWjZVSDZB?oc=5" target="_blank"&gt;Mitsubishi Tanabe pulls Radicava app after skeptical EU regulators ask for new trial&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Mitsubishi Tanabe Pharma America Appoints Sam Shum as Vice President of Operations and Strategy - PR Newswire</title><link>https://news.google.com/rss/articles/CBMi5gFBVV95cUxPU0xiMGtZelZ1LTJQcUdVc3hDZlRpM21mQVRuTHgxQzlKaDNwaHlDNUlXQ09qZ1VRY3hyNVBpdEE4MmZnNUlJTlhqQi1FMjJyTjE5a25aa19vUGhwelpNRWE0eXZDaDVqelF5aDVZUDFXV3BObXYwQV9PZzFlN2pJc1U1TlBXNWdUdnlwUlVTY08zWG0wR2RXWmJvbHpRcWZ4Z21VR0tCcUhEVzZ3RjEwVDNQQWxWMDBQVUdBVzk3dmlUWnp6WjNPNU9iTVo1LTJ5VU9xZEJPR01TLVQxd0RnZlZ0ZFp0QQ?oc=5</link><guid isPermaLink="false">CBMi5gFBVV95cUxPU0xiMGtZelZ1LTJQcUdVc3hDZlRpM21mQVRuTHgxQzlKaDNwaHlDNUlXQ09qZ1VRY3hyNVBpdEE4MmZnNUlJTlhqQi1FMjJyTjE5a25aa19vUGhwelpNRWE0eXZDaDVqelF5aDVZUDFXV3BObXYwQV9PZzFlN2pJc1U1TlBXNWdUdnlwUlVTY08zWG0wR2RXWmJvbHpRcWZ4Z21VR0tCcUhEVzZ3RjEwVDNQQWxWMDBQVUdBVzk3dmlUWnp6WjNPNU9iTVo1LTJ5VU9xZEJPR01TLVQxd0RnZlZ0ZFp0QQ</guid><pubDate>Fri, 01 Mar 2019 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxPU0xiMGtZelZ1LTJQcUdVc3hDZlRpM21mQVRuTHgxQzlKaDNwaHlDNUlXQ09qZ1VRY3hyNVBpdEE4MmZnNUlJTlhqQi1FMjJyTjE5a25aa19vUGhwelpNRWE0eXZDaDVqelF5aDVZUDFXV3BObXYwQV9PZzFlN2pJc1U1TlBXNWdUdnlwUlVTY08zWG0wR2RXWmJvbHpRcWZ4Z21VR0tCcUhEVzZ3RjEwVDNQQWxWMDBQVUdBVzk3dmlUWnp6WjNPNU9iTVo1LTJ5VU9xZEJPR01TLVQxd0RnZlZ0ZFp0QQ?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America Appoints Sam Shum as Vice President of Operations and Strategy&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal - Fierce Biotech</title><link>https://news.google.com/rss/articles/CBMiiwFBVV95cUxQTGdMOHhHZ2dibmV5NGpYcVZuTkRoUnRRcHAtaE5nX0prdFV0eW8xMFpjR1ZCRzN5LTBiV3ZkeEg2UmZRV2NMUzNCaWxTeEpuM3REUzRqdXZCX0FfeEZiaERaRUREc0VUdFBGWDhvWkFQMkNaQ2E2MWxkbnFtT1B0X3NtdDZfNUFOUWdN?oc=5</link><guid isPermaLink="false">CBMiiwFBVV95cUxQTGdMOHhHZ2dibmV5NGpYcVZuTkRoUnRRcHAtaE5nX0prdFV0eW8xMFpjR1ZCRzN5LTBiV3ZkeEg2UmZRV2NMUzNCaWxTeEpuM3REUzRqdXZCX0FfeEZiaERaRUREc0VUdFBGWDhvWkFQMkNaQ2E2MWxkbnFtT1B0X3NtdDZfNUFOUWdN</guid><pubDate>Mon, 24 Jul 2017 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQTGdMOHhHZ2dibmV5NGpYcVZuTkRoUnRRcHAtaE5nX0prdFV0eW8xMFpjR1ZCRzN5LTBiV3ZkeEg2UmZRV2NMUzNCaWxTeEpuM3REUzRqdXZCX0FfeEZiaERaRUREc0VUdFBGWDhvWkFQMkNaQ2E2MWxkbnFtT1B0X3NtdDZfNUFOUWdN?oc=5" target="_blank"&gt;Mitsubishi Tanabe buys up NeuroDerm in $1.1B deal&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Biotech&lt;/font&gt;</description><source url="https://www.fiercebiotech.com">Fierce Biotech</source></item><item><title>Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug - Fierce Biotech</title><link>https://news.google.com/rss/articles/CBMiowFBVV95cUxNR2FBdFNzZnZRSW5QVjBHZFpVdHJnQjR6eGdVckROQmIyWjRYNUl3bWlxUHlrVmdzVkRFWUswRVNET1hvYUE2Z0syQUwzYUY1UGNhY0FIV3hBVHJIZXJOX2xMYjZHWWlFQUdVWFBXVVdIb29YU1FnVUEwU0JsVEU3ZE9tcnFWSThGSHFiMVpST3ZMTFltZUJHdktCeURCUEI2VU1R?oc=5</link><guid isPermaLink="false">CBMiowFBVV95cUxNR2FBdFNzZnZRSW5QVjBHZFpVdHJnQjR6eGdVckROQmIyWjRYNUl3bWlxUHlrVmdzVkRFWUswRVNET1hvYUE2Z0syQUwzYUY1UGNhY0FIV3hBVHJIZXJOX2xMYjZHWWlFQUdVWFBXVVdIb29YU1FnVUEwU0JsVEU3ZE9tcnFWSThGSHFiMVpST3ZMTFltZUJHdktCeURCUEI2VU1R</guid><pubDate>Thu, 25 Apr 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNR2FBdFNzZnZRSW5QVjBHZFpVdHJnQjR6eGdVckROQmIyWjRYNUl3bWlxUHlrVmdzVkRFWUswRVNET1hvYUE2Z0syQUwzYUY1UGNhY0FIV3hBVHJIZXJOX2xMYjZHWWlFQUdVWFBXVVdIb29YU1FnVUEwU0JsVEU3ZE9tcnFWSThGSHFiMVpST3ZMTFltZUJHdktCeURCUEI2VU1R?oc=5" target="_blank"&gt;Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Biotech&lt;/font&gt;</description><source url="https://www.fiercebiotech.com">Fierce Biotech</source></item><item><title>Mitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion - Chemistry World</title><link>https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSG5UazJEUDJXb2MweGVxUTlQYk9DdFZVeUFhUXVzQTBxVGJ0bTZFOHRRaUZsZHdTX1ZoQ0NDVU1xTzhEalhXNlMxLTJPUEhvQ1RzcElWMllzXzZ6TUhyOGJMSV9mbHVvUEN0WHA1R2JueXZYdEZrS1gyYzN2SEpfMDZoTUhuMUM3aDRRZzFNdEtVOFd3M1BjMDV1ZUJvd2FyRGdmWlZUU2g0UQ?oc=5</link><guid isPermaLink="false">CBMiqgFBVV95cUxOSG5UazJEUDJXb2MweGVxUTlQYk9DdFZVeUFhUXVzQTBxVGJ0bTZFOHRRaUZsZHdTX1ZoQ0NDVU1xTzhEalhXNlMxLTJPUEhvQ1RzcElWMllzXzZ6TUhyOGJMSV9mbHVvUEN0WHA1R2JueXZYdEZrS1gyYzN2SEpfMDZoTUhuMUM3aDRRZzFNdEtVOFd3M1BjMDV1ZUJvd2FyRGdmWlZUU2g0UQ</guid><pubDate>Tue, 25 Jul 2017 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSG5UazJEUDJXb2MweGVxUTlQYk9DdFZVeUFhUXVzQTBxVGJ0bTZFOHRRaUZsZHdTX1ZoQ0NDVU1xTzhEalhXNlMxLTJPUEhvQ1RzcElWMllzXzZ6TUhyOGJMSV9mbHVvUEN0WHA1R2JueXZYdEZrS1gyYzN2SEpfMDZoTUhuMUM3aDRRZzFNdEtVOFd3M1BjMDV1ZUJvd2FyRGdmWlZUU2g0UQ?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chemistry World&lt;/font&gt;</description><source url="https://www.chemistryworld.com">Chemistry World</source></item><item><title>How robotic process automation is solving Japan’s demographic woes - ERP Today</title><link>https://news.google.com/rss/articles/CBMikwFBVV95cUxQeEpVQmJzaGxmSDBZbVVpZkswMTJiUTdaU2o0MWQ4QjRTZ09tT21oRm1MZ1M5amNGOEVBd2d1ZlZ6Zl8wc0pFLUMwZGs5c09YbjBWNEI1Z3dkcVMzQlpBQll4MnFMbGdWNnY3NlVGVGFuSGJYem85Q2VsbHlsQjB2Z0UyNUdwRXh6cFhOQUdScmpBMnc?oc=5</link><guid isPermaLink="false">CBMikwFBVV95cUxQeEpVQmJzaGxmSDBZbVVpZkswMTJiUTdaU2o0MWQ4QjRTZ09tT21oRm1MZ1M5amNGOEVBd2d1ZlZ6Zl8wc0pFLUMwZGs5c09YbjBWNEI1Z3dkcVMzQlpBQll4MnFMbGdWNnY3NlVGVGFuSGJYem85Q2VsbHlsQjB2Z0UyNUdwRXh6cFhOQUdScmpBMnc</guid><pubDate>Tue, 11 Apr 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQeEpVQmJzaGxmSDBZbVVpZkswMTJiUTdaU2o0MWQ4QjRTZ09tT21oRm1MZ1M5amNGOEVBd2d1ZlZ6Zl8wc0pFLUMwZGs5c09YbjBWNEI1Z3dkcVMzQlpBQll4MnFMbGdWNnY3NlVGVGFuSGJYem85Q2VsbHlsQjB2Z0UyNUdwRXh6cFhOQUdScmpBMnc?oc=5" target="_blank"&gt;How robotic process automation is solving Japan’s demographic woes&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;ERP Today&lt;/font&gt;</description><source url="https://erp.today">ERP Today</source></item><item><title>Mitsubishi Tanabe Pharma America Appoints Joseph Scalia as Vice President of Sales and Marketing - PR Newswire</title><link>https://news.google.com/rss/articles/CBMi5wFBVV95cUxQLWlLcEgxejJFR2JRblA2VVh0NjZKbkpMdWdwb1NRVEVEX3lUSTAwVVY4VWtfdndFT3lKSDM4RGwtb1JvOXMzUG5nSl9HdDZyeGFrbDVYNXhQRzlGaUZpOHV3TG1GbVY1cFhRLV9CdTJ5SWZHUE1mZEMyMVlnaV9ubXQ1YkRGU3lqRXI3ajVrcTVCWE9JTmgzcGpGaGFwaDFxaDdhOHBwY2oyVEpHRm1mdy1Tdlo5c1B4MUQweDF0bEdQT1Vjb01ZV19KSzI5U0poS1N4NVZTcHNEWlFIa3otcFA2a3JXNjQ?oc=5</link><guid isPermaLink="false">CBMi5wFBVV95cUxQLWlLcEgxejJFR2JRblA2VVh0NjZKbkpMdWdwb1NRVEVEX3lUSTAwVVY4VWtfdndFT3lKSDM4RGwtb1JvOXMzUG5nSl9HdDZyeGFrbDVYNXhQRzlGaUZpOHV3TG1GbVY1cFhRLV9CdTJ5SWZHUE1mZEMyMVlnaV9ubXQ1YkRGU3lqRXI3ajVrcTVCWE9JTmgzcGpGaGFwaDFxaDdhOHBwY2oyVEpHRm1mdy1Tdlo5c1B4MUQweDF0bEdQT1Vjb01ZV19KSzI5U0poS1N4NVZTcHNEWlFIa3otcFA2a3JXNjQ</guid><pubDate>Mon, 24 Sep 2018 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxQLWlLcEgxejJFR2JRblA2VVh0NjZKbkpMdWdwb1NRVEVEX3lUSTAwVVY4VWtfdndFT3lKSDM4RGwtb1JvOXMzUG5nSl9HdDZyeGFrbDVYNXhQRzlGaUZpOHV3TG1GbVY1cFhRLV9CdTJ5SWZHUE1mZEMyMVlnaV9ubXQ1YkRGU3lqRXI3ajVrcTVCWE9JTmgzcGpGaGFwaDFxaDdhOHBwY2oyVEpHRm1mdy1Tdlo5c1B4MUQweDF0bEdQT1Vjb01ZV19KSzI5U0poS1N4NVZTcHNEWlFIa3otcFA2a3JXNjQ?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma America Appoints Joseph Scalia as Vice President of Sales and Marketing&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Eli Lilly Japan inks deal with Mitsubishi Tanabe for diabetes treatment - BioSpectrum Asia</title><link>https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWFZzV1d4R2V0WFY1aXhDTFpsZm96NDJDdE1IUV9JTVpjMzFtYVhubjVCZHM3LVZDRGtoYzlIMzNDVEItNWFZZi1FYjVNVlhoMWs1UnRZMjNVUGh1ZU5OQUo0NERuVWN0Z2VUcEs3OHRlcTBwQWtVQWRLTTFzMHBQNWFjeGRwckdPcGVscG4wVFdnQ3pta3dyUGF5aTZ4RFlQSnMxTlhveUk5T3NPaXRwYWllT1NVZE5vUlp3eGg4eVc?oc=5</link><guid isPermaLink="false">CBMiwAFBVV95cUxPWFZzV1d4R2V0WFY1aXhDTFpsZm96NDJDdE1IUV9JTVpjMzFtYVhubjVCZHM3LVZDRGtoYzlIMzNDVEItNWFZZi1FYjVNVlhoMWs1UnRZMjNVUGh1ZU5OQUo0NERuVWN0Z2VUcEs3OHRlcTBwQWtVQWRLTTFzMHBQNWFjeGRwckdPcGVscG4wVFdnQ3pta3dyUGF5aTZ4RFlQSnMxTlhveUk5T3NPaXRwYWllT1NVZE5vUlp3eGg4eVc</guid><pubDate>Thu, 07 Jul 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWFZzV1d4R2V0WFY1aXhDTFpsZm96NDJDdE1IUV9JTVpjMzFtYVhubjVCZHM3LVZDRGtoYzlIMzNDVEItNWFZZi1FYjVNVlhoMWs1UnRZMjNVUGh1ZU5OQUo0NERuVWN0Z2VUcEs3OHRlcTBwQWtVQWRLTTFzMHBQNWFjeGRwckdPcGVscG4wVFdnQ3pta3dyUGF5aTZ4RFlQSnMxTlhveUk5T3NPaXRwYWllT1NVZE5vUlp3eGg4eVc?oc=5" target="_blank"&gt;Eli Lilly Japan inks deal with Mitsubishi Tanabe for diabetes treatment&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;BioSpectrum Asia&lt;/font&gt;</description><source url="https://www.biospectrumasia.com">BioSpectrum Asia</source></item><item><title>Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award - PR Newswire</title><link>https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNXhEZ1JXLTdPYzBIdnVLTWw0SG83SDlhX2RxRnl3NkQzbHgzWjRoaHVLYW9PamctX0tuc0hlNVkzd3phRHN0UmdpdW14TjM0dDNtT3BXcFV1aUs2T0gwXzNqVURqRmViRDEyVGpGeUI3TksxTXpOQmFMck1JRWFMODJlWUk1YzZyaWhSSkxkNkhvX1pWam1qUF9JRDRkcXFyTzFsVTM4aGhGd0o1RE5MV1VaM2xTcjdyWVFTanR5M1RfRFY4RDZWemlqU096NUxjQmFqTlhkcWlMVmF3dkdpMFFqZHVEQUpqb0FjTjlhZUtOMnB3cXRhV29EZw?oc=5</link><guid isPermaLink="false">CBMi-wFBVV95cUxPNXhEZ1JXLTdPYzBIdnVLTWw0SG83SDlhX2RxRnl3NkQzbHgzWjRoaHVLYW9PamctX0tuc0hlNVkzd3phRHN0UmdpdW14TjM0dDNtT3BXcFV1aUs2T0gwXzNqVURqRmViRDEyVGpGeUI3TksxTXpOQmFMck1JRWFMODJlWUk1YzZyaWhSSkxkNkhvX1pWam1qUF9JRDRkcXFyTzFsVTM4aGhGd0o1RE5MV1VaM2xTcjdyWVFTanR5M1RfRFY4RDZWemlqU096NUxjQmFqTlhkcWlMVmF3dkdpMFFqZHVEQUpqb0FjTjlhZUtOMnB3cXRhV29EZw</guid><pubDate>Thu, 28 Apr 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNXhEZ1JXLTdPYzBIdnVLTWw0SG83SDlhX2RxRnl3NkQzbHgzWjRoaHVLYW9PamctX0tuc0hlNVkzd3phRHN0UmdpdW14TjM0dDNtT3BXcFV1aUs2T0gwXzNqVURqRmViRDEyVGpGeUI3TksxTXpOQmFMck1JRWFMODJlWUk1YzZyaWhSSkxkNkhvX1pWam1qUF9JRDRkcXFyTzFsVTM4aGhGd0o1RE5MV1VaM2xTcjdyWVFTanR5M1RfRFY4RDZWemlqU096NUxjQmFqTlhkcWlMVmF3dkdpMFFqZHVEQUpqb0FjTjlhZUtOMnB3cXRhV29EZw?oc=5" target="_blank"&gt;Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Mitsubishi Tanabe lands '$940m' revenue boost after Novartis win - Managing Intellectual Property</title><link>https://news.google.com/rss/articles/CBMiugFBVV95cUxOQWFfQnB5ZFYtTi1EUWRNN2dwaWNSaVl2aVZyVlZadmZpc2t6Sll4aGZXMW1MbEJFTkE3WmtoREk2cjBFblc0OElJTTlOeXF2c01KN0dEbFlMRTV2X2RtTU9ManNDRF9GNnphVXR5N0otUUZiM3hHSEJJSEFfNmVaY09Xb2ZwS3JCSXJMR0hWY1drYlEtZUVmcmhkQVZWWmJ5UERHN1NYc0VkaXBvMmtQOU1KOFFrTDV2TXc?oc=5</link><guid isPermaLink="false">CBMiugFBVV95cUxOQWFfQnB5ZFYtTi1EUWRNN2dwaWNSaVl2aVZyVlZadmZpc2t6Sll4aGZXMW1MbEJFTkE3WmtoREk2cjBFblc0OElJTTlOeXF2c01KN0dEbFlMRTV2X2RtTU9ManNDRF9GNnphVXR5N0otUUZiM3hHSEJJSEFfNmVaY09Xb2ZwS3JCSXJMR0hWY1drYlEtZUVmcmhkQVZWWmJ5UERHN1NYc0VkaXBvMmtQOU1KOFFrTDV2TXc</guid><pubDate>Mon, 20 Feb 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOQWFfQnB5ZFYtTi1EUWRNN2dwaWNSaVl2aVZyVlZadmZpc2t6Sll4aGZXMW1MbEJFTkE3WmtoREk2cjBFblc0OElJTTlOeXF2c01KN0dEbFlMRTV2X2RtTU9ManNDRF9GNnphVXR5N0otUUZiM3hHSEJJSEFfNmVaY09Xb2ZwS3JCSXJMR0hWY1drYlEtZUVmcmhkQVZWWmJ5UERHN1NYc0VkaXBvMmtQOU1KOFFrTDV2TXc?oc=5" target="_blank"&gt;Mitsubishi Tanabe lands '$940m' revenue boost after Novartis win&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Managing Intellectual Property&lt;/font&gt;</description><source url="https://www.managingip.com">Managing Intellectual Property</source></item><item><title>Mitsubishi Tanabe Pharma Canada’s commitment to Canadians living with ALS - Macleans.ca</title><link>https://news.google.com/rss/articles/CBMiiAFBVV95cUxPaVZCR2dCWjF0ZGNuVFhxM194ZUVYN2pxOXA2UGpRT0Y0bElQVjZhQU40emtGR1lzSi12RXJBWHBvM3gzOG9TRUs0d240M3dSVVV3cXJ2b3M5cE1VdXN3NjdKak95U3FuelFXOVdheS1INFhJSDlsb3dMZ3VKMEpOb3lVTW9oWTRG?oc=5</link><guid isPermaLink="false">CBMiiAFBVV95cUxPaVZCR2dCWjF0ZGNuVFhxM194ZUVYN2pxOXA2UGpRT0Y0bElQVjZhQU40emtGR1lzSi12RXJBWHBvM3gzOG9TRUs0d240M3dSVVV3cXJ2b3M5cE1VdXN3NjdKak95U3FuelFXOVdheS1INFhJSDlsb3dMZ3VKMEpOb3lVTW9oWTRG</guid><pubDate>Thu, 14 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPaVZCR2dCWjF0ZGNuVFhxM194ZUVYN2pxOXA2UGpRT0Y0bElQVjZhQU40emtGR1lzSi12RXJBWHBvM3gzOG9TRUs0d240M3dSVVV3cXJ2b3M5cE1VdXN3NjdKak95U3FuelFXOVdheS1INFhJSDlsb3dMZ3VKMEpOb3lVTW9oWTRG?oc=5" target="_blank"&gt;Mitsubishi Tanabe Pharma Canada’s commitment to Canadians living with ALS&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Macleans.ca&lt;/font&gt;</description><source url="https://macleans.ca">Macleans.ca</source></item><item><title>Invokana (canagliflozin) for the Treatment of Type 2 Diabetes - Clinical Trials Arena</title><link>https://news.google.com/rss/articles/CBMiqwFBVV95cUxNaDRISDhQOThrc2l3UnBLTDVIUnpGWTcwUFl5bEJfM0cwQjFJNTFGMUtoTGJwWU1TZi12aFZoWkJ5SlZlRVlnelRrM1VaTjF1ckRmbWdtbFhCOTluME5wZ3RpZmJrVEptYjc3bXdaZXU1Um0tSnU2YjZkY0h0Z1ZscnZhTUF2aXFIRG9FWmVocWRHUklQV3VOM1g2Q1lIRVJQeTZqQ1dBZFM2cUk?oc=5</link><guid isPermaLink="false">CBMiqwFBVV95cUxNaDRISDhQOThrc2l3UnBLTDVIUnpGWTcwUFl5bEJfM0cwQjFJNTFGMUtoTGJwWU1TZi12aFZoWkJ5SlZlRVlnelRrM1VaTjF1ckRmbWdtbFhCOTluME5wZ3RpZmJrVEptYjc3bXdaZXU1Um0tSnU2YjZkY0h0Z1ZscnZhTUF2aXFIRG9FWmVocWRHUklQV3VOM1g2Q1lIRVJQeTZqQ1dBZFM2cUk</guid><pubDate>Thu, 04 Apr 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNaDRISDhQOThrc2l3UnBLTDVIUnpGWTcwUFl5bEJfM0cwQjFJNTFGMUtoTGJwWU1TZi12aFZoWkJ5SlZlRVlnelRrM1VaTjF1ckRmbWdtbFhCOTluME5wZ3RpZmJrVEptYjc3bXdaZXU1Um0tSnU2YjZkY0h0Z1ZscnZhTUF2aXFIRG9FWmVocWRHUklQV3VOM1g2Q1lIRVJQeTZqQ1dBZFM2cUk?oc=5" target="_blank"&gt;Invokana (canagliflozin) for the Treatment of Type 2 Diabetes&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Clinical Trials Arena&lt;/font&gt;</description><source url="https://www.clinicaltrialsarena.com">Clinical Trials Arena</source></item></channel></rss>